Roche Unveils $50B U.S. Manufacturing Expansion, Marking Largest-Ever Investment in U.S. Operations
Swiss pharmaceutical leader Roche is making a historic bet on the U.S. life sciences sector, announcing a $50 billion investment over the next five years to dramatically expand its American manufacturing and research footprint. The move underscores a strategic pivot that could soon see the U.S. become a net exporter of Roche medicines, according to […]
Continue Reading